摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-Di-n-propyl-imidazol | 37455-57-5

中文名称
——
中文别名
——
英文名称
2,4-Di-n-propyl-imidazol
英文别名
2,4-dipropyl-1(3)H-imidazole;2,5-Dipropyl-1H-imidazole
2,4-Di-n-propyl-imidazol化学式
CAS
37455-57-5
化学式
C9H16N2
mdl
——
分子量
152.239
InChiKey
YSMLZMWPDIHEJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    28.7
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    1-cyano-2,5-dipropylimidazole 在 氢氧化钾 作用下, 以 甲醇 为溶剂, 反应 14.0h, 以91%的产率得到2,4-Di-n-propyl-imidazol
    参考文献:
    名称:
    Watanabe, T.; Nishiyama, J.; Hirate, R., Journal of Heterocyclic Chemistry, 1983, vol. 20, p. 1277 - 1281
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] COMPLEXES OF IMIDAZOLE LIGANDS<br/>[FR] COMPLEXES DE LIGANDS IMIDAZOLES
    申请人:AIR PROD & CHEM
    公开号:WO2011156699A1
    公开(公告)日:2011-12-15
    Metal imidazolate complexes are described where imidazoles ligands functionalized with bulky groups and their anionic counterpart, i.e., imidazolates are described. Compounds comprising one or more such polyalkylated imidazolate anions coordinated to a metal or more than one metal, selected from the group consisting of alkali metals, transition metals, lanthanide metals, actinide metals, main group metals, including the chalcogenides, are contemplated. Alternatively, multiple different imidazole anions, in addition to other different anions, can be coordinated to metals to make new complexes. The synthesis of novel compounds and their use to form thin metal containing films is also contemplated.
    金属咪唑酸盐配合物的描述中,描述了咪唑配体上带有大体积基团的功能化咪唑和它们的阴离子对应物,即咪唑酸盐。考虑到由一个或多个这种多烷基化咪唑阴离子配位到一种或多种金属的化合物,所述金属选自碱金属、过渡金属、镧系金属、锕系金属、主族金属,包括硫属元素。或者,可以将多种不同的咪唑阴离子以及其他不同的阴离子配位到金属上以形成新的配合物。还考虑到合成新化合物并将其用于形成含金属薄膜的用途。
  • Nitrogen-containing fused heterocyclic compounds
    申请人:Gyorkos Charles Albert
    公开号:US20070135452A1
    公开(公告)日:2007-06-14
    There is provided a CRF receptor antagonist comprising a compound of the formula (I): wherein, ring A is a 5-membered ring represented by the formula (A′): wherein X is a carbon and X 1 is an oxygen, a sulfur or —NR 5 —, or formula (A″): wherein X is a nitrogen and R 6 is an optionally substituted hydrocarbyl, R 1 is an amino substituted by two optionally substituted hydrocarbyl groups, R 2 is an phenyl, Y 1 is CR 3a or a nitrogen, y 2 is CR 3b or a nitrogen and Y 3 is CR 3c or a nitrogen, provided that one or less of Y 1 , Y 2 , and Y 3 is nitrogen, W is a bond, —(CH 2 )n-, and Z is a bond, —NR 4 —, etc.; or a salt thereof or a prodrug thereof.
    提供了一种CRF受体拮抗剂,包括式(I)的化合物:其中,环A是由式(A')表示的5元环:其中X是碳,X1是氧、硫或—NR5—,或由式(A'')表示的环:其中X是氮,R6是可选取代的烃基,R1是氨基,由两个可选取代的烃基基团取代,R2是苯基,Y1是CR3a或氮,y2是CR3b或氮,Y3是CR3c或氮,但Y1、Y2和Y3中至多一个是氮,W是键,—(CH2)n—,Z是键,—NR4—等;或其盐或前药。
  • Complexes Of Imidazole Ligands
    申请人:Norman John Anthony Thomas
    公开号:US20120121806A1
    公开(公告)日:2012-05-17
    Metal imidazolate complexes are described where imidazoles ligands functionalized with bulky groups and their anionic counterpart, i.e., imidazolates are described. Compounds comprising one or more such polyalkylated imidazolate anions coordinated to a metal or more than one metal, selected from the group consisting of alkali metals, transition metals, lanthanide metals, actinide metals, main group metals, including the chalcogenides, are contemplated. Alternatively, multiple different imidazole anions, in addition to other different anions, can be coordinated to metals to make new complexes. The synthesis of novel compounds and their use to form thin metal containing films is also contemplated.
    本文描述了具有大体积基团的咪唑配体及其阴离子对应物即咪唑酸盐的金属咪唑酸盐络合物。本文考虑了由一种或多种这种多烷基化咪唑酸盐阴离子与一种或多种金属(包括碱金属、过渡金属、稀土金属、锕系金属、主族金属和硫属化物)配位而成的化合物。此外,还可以将多种不同的咪唑酸盐阴离子与其他不同的阴离子配位到金属上,以制备新的络合物。本文还考虑了合成新化合物并将其用于形成含金属薄膜的用途。
  • WATER-ABSORBENT RESIN DISPERSION AND POLYURETHANE COMPOSITION
    申请人:SANYO CHEMICAL INDUSTRIES, LTD.
    公开号:EP0789062A1
    公开(公告)日:1997-08-13
    A water-absorbent resin dispersion comprising a water-absorbent resin (B) or a hydrous gel thereof dispersed in a liquid or heat-meltable organic active-hydrogen compound (A), wherein said resin (B) is formed by the polymerization of a water-soluble monomer or its precursor and a cross-linker and/or a polysaccharide in the compound (A); and a process for producing a polyurethane resin by the reaction of the dispersion with an organic polyisocyanate compound. As the polyurethane resin is excellent in the capacity and rate of absorption, it is useful as absorbent articles such as paper diaper and sanitary goods, humidity modifiers, cutoff material, and so forth.
    一种吸水性树脂分散体,包括分散在液态或可加热熔化的有机活性氢化合物(A)中的吸水性树脂(B)或其水凝胶,其中所述树脂(B)由化合物(A)中的水溶性单体或其前体与交联剂和/或多糖聚合而成;以及一种通过分散体与有机多异氰酸酯化合物反应生产聚氨酯树脂的工艺。由于聚氨酯树脂的吸水能力和吸水速度极佳,因此可用作纸尿布和卫生用品等吸水物品、湿度调节剂、切断材料等。
  • SURFACE-REACTED CALCIUM CARBONATE IN A PROCESS FOR THE PRODUCTION OF A LOADED MICROCAPSULE
    申请人:Omya International AG
    公开号:EP3928859A1
    公开(公告)日:2021-12-29
    The present invention relates to a process for the production of a microcapsule comprising an active ingredient or inactive precursor thereof, as well as a microcapsule obtainable thereby. The process involves the use of a surface-reacted calcium carbonate as a template for encapsulating the active ingredient or inactive precursor thereof. The active ingredient or inactive precursor thereof is loaded onto the surface-reacted calcium carbonate and subsequently encased by a multilayer shell comprising at least two complementary layers using layer-by-layer assembly. Further aspects of the invention relate to the use of a surface-reacted calcium carbonate as a template for encapsulating the active ingredient or inactive precursor thereof, a product comprising said microcapsule, as well as the use of said microcapsule.
    本发明涉及一种包含活性成分或其非活性前体的微胶囊的生产工艺,以及由此获得的微胶囊。该工艺包括使用表面反应碳酸钙作为模板来封装活性成分或非活性前体。将活性成分或其非活性前体装载到表面反应碳酸钙上,然后使用逐层组装法将其包裹在由至少两层互补层组成的多层外壳中。本发明的其他方面涉及使用表面反应碳酸钙作为封装活性成分或非活性前体的模板、包含所述微胶囊的产品以及所述微胶囊的用途。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺